Identification of Novel Targetable Kinases in SR-a GvHD
NCT04342442 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2020-04-13
Summary
In this study, the investigators aim to identify novel targetable kinases in SR-a GvHD patient samples and investigate their role in different immune cell subtypes.
Conditions
Sponsors & Collaborators
-
University of Freiburg
lead OTHER
Principal Investigators
-
Robert Zeiser, Prof. Dr. · University Medical Center Freiburg
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
More Related Trials
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Pathophysiological Study of the Sensitive Scalp
NCT07156422 ·Status: RECRUITING ·Phase: NA
-
Familial Systemic Scleroderma
NCT07343115 ·Status: RECRUITING
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
Personalized Therapy of Patients Suffering From Rare Genodermatoses
NCT05680974 ·Status: UNKNOWN
-
Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
NCT05732987 ·Status: RECRUITING
-
Autoimmune and Inflammatory Response Biomarkers in Fabry Disease
NCT06007768 ·Status: COMPLETED
-
Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging
NCT06568783 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Examining the Immunological Process of Autoimmune Patients
NCT02123147 ·Status: WITHDRAWN
-
Determinants of Chronic Inflammatory Skin Disease Trajectories
NCT05928169 ·Status: RECRUITING
-
Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
NCT06857240 ·Status: RECRUITING ·Phase: PHASE2
-
CAUSE Trial: Patient Specific-Cellular Characterization of Fibromuscular Dysplasia and High-Risk Atherosclerotic Endothelium
NCT01808729 ·Status: COMPLETED
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
NCT01309997 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
NCT02975271 ·Status: TERMINATED ·Phase: PHASE2
-
Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome
NCT06742073 ·Status: RECRUITING
-
Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.
NCT03211325 ·Status: COMPLETED ·Phase: NA
-
Molecular Signatures in Inflammatory Skin Disease
NCT03358693 ·Status: RECRUITING
-
Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
NCT01276314 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Systemic Histiocytosis
NCT07157683 ·Status: NOT_YET_RECRUITING
-
Pleiotropic Role of TRPV1 in Psoriasis Inflammation
NCT04848194 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED